GlucoTrack, Inc. - Common Stock (NQ:GCTK)

Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications

October 14, 2026

Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn

Performance

52-Week Range 99.5% below 52-week high

0.5989

0.5952W Low 112.5052W High

1 Week 31.9% below 1-week high

0.591W Low 0.881W High

GlucoTrack, Inc. - Common Stock (GCTK) traded between $0.59 and $112.50 over the past 52 weeks and last traded at $0.60, 99.5% below its 52-week high. Over the past week it ranged between $0.59 and $0.88.

Past 12 Months

-28.0%

-74.0%

-86.9%

-94.5%

-99.0%

-99.4%

1W -$0.23

1M -$1.70

3M -$3.99

6M -$10.31

YTD -$57.60

1Y -$99.15

GCTK was -99.4% over the past year, -94.5% over six months, -99.0% year to date, -28.0% in the last week.

12 Months vs Market

GCTK

-99.4%

DIA

+12.5%

SPY

+13.8%

QQQ

+15.2%

IWM

+12.0%

Over the past 12 months GCTK returned -99.4% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.08× 3-mo avg

Today 143,506 3-mo avg 1.9M

105.7K

3.7M

1.9M

1.2M

YTD

768.2K

616.4K

GCTK most recently traded 143,506 shares against a 3-month average daily volume of 1.9M.

More News

October 01, 2026

Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14

September 30, 2026

Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session. ↗

Top movers in Friday's session ↗

September 25, 2026

Via Chartmill

September 25, 2026

Via Chartmill

Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™

September 25, 2026

DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region

Emerging Growth DRK GLND APUS GCTK Stocks in the News

September 24, 2026

Via AB Newswire

September 24, 2026

Via AB Newswire

Unusual volume stocks in Thursday's session ↗

September 24, 2026

Via Chartmill

Which stocks are moving on Thursday? ↗

September 24, 2026

Via Chartmill

The market is filled with gapping stocks in Thursday's session. ↗

September 24, 2026

Via Chartmill

Glucotrack, Inc. Announces Pricing of $3 Million Public Offering

September 24, 2026

Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform

Wondering what's happening in today's pre-market session? ↗

September 24, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

September 23, 2026

Via Chartmill

September 23, 2026

Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities

September 23, 2026

Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

September 18, 2026

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

Top movers in Friday's session ↗

September 11, 2026

Via Chartmill

September 11, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Friday's session. ↗

September 11, 2026

Via Chartmill

Glucotrack Announces $11.5 Million Financing

September 11, 2026

Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions

September 08, 2026

From Lōkahi Therapeutics Inc.

Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business

September 02, 2026

Glucotrack, Inc. Announces Reverse Stock Split

August 27, 2026